Clinical trial

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

NCT00142740 · University of North Carolina, Chapel Hill, Other · Completed

Key facts

NCT number NCT00142740
Title Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
Official title Population Genetics and Immune Response to Hepatitis B Vaccination in Adolescents: A Substudy of ATN 024 and ATN 025
Lead sponsor University of North Carolina, Chapel Hill, Other
Collaborators National Institute on Drug Abuse (NIDA) NIH National Institute of Mental Health (NIMH) National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Status Completed
Study type Observational
Conditions HIV Infection, Hepatitis B
Enrollment 337
Start date Oct 1, 2005
Primary completion Jun 1, 2008
Completion Jun 1, 2008
First posted Sep 2, 2005
Last update posted Feb 28, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies